The Current Ratio as of November 2025 (TTM) for ISR Immune System Regulation Holding AB (publ) (ISR.ST) is 3.27

According to ISR Immune System Regulation Holding AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 3.27. This represents a change of -25.60% compared to the average of 4.40 of the last 4 quarters.

ISR Immune System Regulation Holding AB (publ) (ISR.ST) Historical Current Ratio (quarterly & annually)

How has ISR.ST Current Ratio performed in the past?

The mean historical Current Ratio of ISR Immune System Regulation Holding AB (publ) over the last ten years is 8.11. The current 3.27 Current Ratio has changed 3.93% with respect to the historical average. Over the past ten years (40 quarters), ISR.ST's Current Ratio was at its highest in in the June 2017 quarter at 19.35. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

ISR Immune System Regulation Holding AB (publ) (ISR.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ISR Immune System Regulation Holding AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ISR Immune System Regulation Holding AB (publ) (ISR.ST) Average Current Ratio

How has ISR.ST Current Ratio performed in the past?

The current Current Ratio of ISR Immune System Regulation Holding AB (publ) (ISR.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ISR Immune System Regulation Holding AB (publ) (ISR.ST) Current Ratio vs. Peers

How is ISR.ST’s Current Ratio compared to its peers?

ISR Immune System Regulation Holding AB (publ)’s Current Ratio is less than CombiGene AB (publ) (17.47), greater than Idogen AB (publ) (1.67), less than Kancera AB (publ) (8.02), less than Pharmiva AB (publ) (5.46), less than Cyxone AB (publ) (4.01), greater than Ziccum AB (publ) (0.36), greater than Scandion Oncology A/S (1.81), greater than Amniotics AB (publ) (1.17), greater than Asarina Pharma AB (publ) (1.20), greater than Toleranzia AB (0.71),

Build a custom stock screener for ISR Immune System Regulation Holding AB (publ) (ISR.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ISR Immune System Regulation Holding AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ISR Immune System Regulation Holding AB (publ) (ISR.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ISR Immune System Regulation Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.